Author

V. H. Pomin

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1 Microbiology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Organism:human· 2 Research Focus:cancer & tumor microenvironment· 1 Research Focus:host-pathogen & immune response· 1

Frequent Co-Authors

A. Panigrahi· 1 shared D. Mitra· 1 shared F. Zhang· 1 shared H. Liu· 1 shared J. Benicky· 1 shared J. Liu· 1 shared J. S. Sharp· 1 shared L. Ailles· 1 shared

Activity by Year

2020-2023 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 20 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

A. Panigrahi

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Heparan-6-O-endosulfatase 2 promotes invasiveness of head and neck squamous carcinoma cell lines in co-cultures with cancer associated fibroblasts

P. Mukherjee, X. Zhou, J. Benicky, A. Panigrahi, R. Aljuhani, J. Liu, L. Ailles, V. H. Pomin, Z. Wang, R. Goldman

This study shows that Sulf-2 promotes HNSCC cell invasion in co-cultures with CAFs, and a marine glycosaminoglycan inhibits this effect.

bioRxiv · Oct 5, 2023Cancer Biology

Effective Inhibition of SARS-CoV-2 Entry by Heparin and Enoxaparin Derivatives

R. Tandon, J. S. Sharp, F. Zhang, V. H. Pomin, N. M. Ashpole, D. Mitra, W. Jin, H. Liu, P. Sharma, R. J. Linhardt

This study evaluates the antiviral activity of heparin and enoxaparin derivatives against SARS-CoV-2 by testing their ability to neutralize pseudotyped virus particles.

bioRxiv · Jun 8, 2020Microbiology